$ALAB

Astera Labs, Inc.

5
1
2
$122.6M
ALBA MANUEL
45%
See all $ALAB insider activity →

Dyckerhoff Stefan A sold $964K of ALAB

Dyckerhoff Stefan A sold 3,505 shares of Astera Labs, Inc. (ALAB) at an average of $274.96 ($273.64–$276.75, $0.96M total) across 4 trades on 2026-09-02 under a Rule 10b5-1 trading plan.

ALBA MANUEL sold $51.3M of ALAB (indirect holdings)

ALBA MANUEL sold 183,000 indirectly-held shares of Astera Labs, Inc. (ALAB) at an average of $280.13 ($277.32–$288.95, $51.26M total) across 24 trades on 2026-09-01 under a Rule 10b5-1 trading plan.

ALAB sentiment & insider activity

Over the past 7 days, alphai's AI scored 8 news stories mentioning ALAB (Astera Labs, Inc.). Coverage has skewed bullish: 5 bullish, 1 neutral, and 2 bearish.

Recent ALAB coverage spans insider activity, earnings and corporate actions.

In the last 30 days, ALAB insiders filed 99 SEC Form 4 transactions — no purchases and 99 sales ($122.6M). The most active reporter was ALBA MANUEL with 24 filings. 45% of those filings were made under pre-arranged Rule 10b5-1 plans.

What's driving ALAB

  • The insider sale may signal a neutral to slightly negative sentiment, but the amount is modest relative to market cap.

    SEC EDGAR · Sep 3, 2026

  • This is an insider sale disclosure, not a fundamental update; it may slightly affect sentiment but is unlikely to change near-term valuation on its own.

    SEC EDGAR · Sep 3, 2026

  • Large insider sell may signal negative sentiment and could pressure the stock lower.

    SEC EDGAR · Sep 3, 2026

  • Strong revenue growth and strategic Amazon partnership could boost stock momentum.

    yahoo.com · Sep 3, 2026

  • Guidance indicates strong sequential growth and modest profitability expectations.

    247wallst.com · Sep 1, 2026

alphai scores every news story that mentions ALAB with an AI model for sentiment and relevance, and aggregates insider trades from Astera Labs, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $ALAB

Score
$ALABMed

3 Millionaire-Maker Artificial Intelligence (AI) Stocks to Buy Now

Astera Labs (ALAB) reported Q1 2026 revenue of $308.4M, up 93% YoY, with 76.3% gross margin. Credo Technology (CRDO) saw Q2 2026 revenue of $268M, up 272% YoY, and guided for over 200% FY growth. Vertiv (VRT) reported a $15B backlog with a 2.9 book-to-bill ratio in Q4 2025, expanding liquid cooling capacity. All three companies are involved in AI infrastructure.

Global Bond Rout Sparks Tech Selloff: 5 Stocks Fall Over 5% - Invesco QQQ Trust, Series 1 (NASDAQ:QQQ), C

U.S. 10-year Treasury yield hit 4.80%, highest since 2025, amid global bond market surge. Tech stocks fell, with Nasdaq Composite down 0.7% and Invesco QQQ Trust (QQQ) down 1%. Five Nasdaq 100 stocks dropped over 5%, including CrowdStrike (CRWD) and Astera Labs (ALAB). Higher yields increase borrowing costs and reduce future profit valuations for tech firms.

Yuanta Sees NVIDIA MediaTek Deal Strengthening AI Infrastructure Market Reach

Yuanta Securities highlights NVIDIA's expanded partnership with MediaTek, including a $3.5B investment, to strengthen AI infrastructure. MediaTek will join NVIDIA's NVLink Fusion ecosystem, enabling custom XPU designs for data centers, devices, and automotive platforms. Yuanta sees potential benefits for NVIDIA, MediaTek, Marvell, Astera Labs, Broadcom, Synopsys, Cadence, and TSMC.

HighAI 9/10

Astera Labs Stock Soars 116% on Record AI Connectivity Chip Revenue

Astera Labs reported Q2 revenue of $392.4M, up 104% YoY, beating estimates. The company's stock surged 116%, closing at $289.47 with a market cap of $50.22B. Astera's chips, retimers, and switches support AI infrastructure, with record revenue from its Aries and Scorpio product lines. The company guided Q3 revenue to $540M-$560M, with strong profit margins. Analysts have a buy consensus and an average price target of $389.95.

Astera Labs (ALAB) Stock May Trade At A Premium Following Its 61% Run

Astera Labs (ALAB) stock has risen 61.2% year-to-date, trading at a premium according to valuation metrics. The DCF model estimates intrinsic value at $267 per share, slightly below the current price, suggesting an 8.6% overvaluation. The P/E ratio of 135.9x is significantly higher than industry and peer averages, indicating a rich valuation. Analysts are divided on the stock's future prospects, with bulls citing partnerships and bears highlighting concentration risks.

Related tickers